Browsing: Technologies

Aug. 18, 2026 /CNW/ — Forward Water Technologies Corp. (“FWTC” or the “Company”) (TSXV: FWTC) announces that it has elected to voluntarily adopt semi-annual financial reporting and rely on the exemptions provided under Coordinated Blanket Order 51-933 – Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers (“CBO 51-933”)

Welcome to our dedicated page for HYDRO POWER TECHNOLOGIES SEC filings (Ticker: PCGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Exyn Technologies, Inc. notified that it will file its Form 10-Q for the quarter ended June 30, 2026 late. The Audit Committee, assisted by outside counsel, is conducting an internal investigation into allegations regarding use of a company credit card by an executive officer, and the company has placed that officer on leave. Because the…

SalesCloser Technologies Ltd. is a Canadian artificial intelligence software company focused on developing autonomous AI sales agents that help businesses automate customer interactions throughout the sales cycle. The company’s platform is designed to support activities including lead qualification, product demonstrations, follow-up communication, appointment scheduling and customer engagement through voice, video and digital channels.

Roper TechnologiesNASDAQ: ROP is pursuing a strategy centered on long-term free-cash-flow-per-share growth, portfolio collaboration and acquisitions of vertical-market software businesses, while increasingly deploying artificial intelligence across its operations and products, Chief Financial Officer Jason Conley said at the Oppenheimer Technology Conference.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any enquiries.

Anteris Technologies Global Corp. reported continued operating losses as it advances development of its DurAVR® transcatheter heart valve system and global pivotal Trial. Net sales from legacy tissue products were modest at $1.5 million for the six months ended June 30 2026, up 28% year over year, while the business remains primarily R&D-focused.

This is a paid press release. Contact the press release distributor directly with any inquiries.

Fisent Technologies has raised $4.3 million in a venture funding round led by FINTOP to expand the adoption of its generative AI process automation technology among regulated enterprises.